AIMOVIG

ERENUMAB-AOOE · Amgen Inc

Drug timelines are a Plus or Pro feature.

30 regulatory and trial events tracked for AIMOVIG, covering 2018-05-17 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine [Phase 3]